Modified Cobrotoxin

Snake Venom Source: Cobra (Naja naja atra)

Research Aim: Anti-HIV/HCV/ Herpes

Modified Cobrotoxin inhibits the entry of several viruses that are known to cause severe neurological damage in such diseases as rabies, encephalitis, and AIDS. Modified Cobrotoxin is being developed firstly for the treatment of HIV,it is effective against drug-resistant strains of HIV, and is being studied in preclinical assays for its efficacy in treating HIV/AIDS.

Research Phase: Phase 1

Modified Cobrotoxin inhibits the entry of several viruses that are known to cause severe neurological damage in such diseases as rabies, encephalitis, and AIDS. Modified Cobrotoxin is being developed firstly for the treatment of HIV,it is effective against drug-resistant strains of HIV, and is being studied in preclinical assays for its efficacy in treating HIV/AIDS.
Modified Cobrotoxin has already been proven to have broad antiviral activity and a well established safety record in humans. Recent laboratory studies revealed that Modified Cobrotoxin was capable of inhibiting the replication of HIV as efficiently as normal or wild-type strains. It has a great impact on resistant strains of HIV may help in the drug's progression through clinical trials.
ORIENTOXIN BIOTECH is filing for the application of PhaseⅠClinical trials. The trial is expected to start in the last quarter of 2007.

^TOP^